We are live on
!
Find out more
ADC Therapeutics
ADCT
ADCT
118 hedge funds and large institutions have $313M invested in ADC Therapeutics in 2026 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 53 increasing their positions, 28 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
24,967% more call options, than puts
Call options by funds: $752K | Put options by funds: $3K
89% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 28
36% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 14
7% more capital invested
Capital invested by funds: $293M → $313M (+$20.1M)
3% more funds holding
Funds holding: 115 → 118 (+3)
1.16% less ownership
Funds ownership: 66.89% → 65.74% (-1.2%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
118
Holders Change
+3
Holders Change %
+2.61%
% of All Funds
1.45%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.02%
New
19
Increased
53
Reduced
28
Closed
14
Calls
$752K
Puts
$3K
Net Calls
+$749K
Net Calls Change
+$625K
Top Buyers
| 1 |
Millennium Management
New York
|
+$11M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$9.22M |
| 3 |
BlackRock
New York
|
+$3.25M |
| 4 |
Two Sigma Investments
New York
|
+$2.16M |
| 5 |
Renaissance Technologies
New York
|
+$1.18M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$17.8M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.44M |
| 3 |
SC
Stempoint Capital
New York
|
-$1.77M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$774K |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$699K |
